| TRADING CENTER |
| 3rd UPDATE: Roche Says Diabetes Drug Better Than Merck Januvia - Dow Jones | |
| 2nd UPDATE:Roche Says Diabetes Drug Better Than Merck Januvia - Dow Jones |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.36 | 0.20 / 0.31% | 14.05 |
| PFE | Pfizer Inc | 18.49 | -0.15 / -0.80% | 15.54 |
| NVS | Novartis AG | 55.55 | -0.23 / -0.41% | 15.60 |
| 2008 Revenue: | $8.5 B | Headquarters: Bagsvaerd, |
| Employees: | 27,068 | CEO: Lars Rebien Sorensen |
| Net Income: | $1.8 B | Industry: Pharmaceuticals |
| Market Cap: | $35.6 B | Website: www.novonordisk.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| NVO | 67.11 | -0.55 / -0.81% | 67.66 | 68.05 | 66.95 | Profile Chart News |